Therapy for injured muscles

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S009100, C514S012200, C530S350000, C530S412000, C435S069100, C435S320100, C435S252300, C536S023100

Reexamination Certificate

active

06955813

ABSTRACT:
Methods for treating an injured muscle by local administration of a neurotoxin, such as a botulinum toxin, to promote healing and/or to reduce the pain associated with an injured muscle.

REFERENCES:
patent: 5721215 (1998-02-01), Aoki et al.
patent: 6063768 (2000-05-01), First
patent: 6423319 (2002-07-01), Brooks et al.
patent: 6447787 (2002-09-01), Gassner et al.
patent: 9415629 (1994-07-01), None
patent: WO 94/28923 (1994-12-01), None
patent: WO 95/17904 (1995-07-01), None
patent: WO95/17904 (1995-07-01), None
patent: WO 00/24419 (2000-05-01), None
Trotter et al., Treatment of Subtotal medial Rectus Myectomy Complicating Functional Endoscopic Sinus Surgery. J. AAPOS 4, 250-253 (Aug. 2000).
Garrett, Jr., et al. The American Journal of Sports Medicine, V.24No. 6, 1996.
Jarvinen, et al, Current Opinion in Rheumatology, 2000, 12:155-161.
Morre, et al, Lancet 1997; 349 (9067): 1746.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Therapy for injured muscles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapy for injured muscles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapy for injured muscles will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3436530

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.